Lin-Quan Wu

Papers

Total Citations

H-Index

About

Lin-Quan Wu is a pioneering surgeon-scientist whose research centers on advancing minimally invasive surgical techniques for hepatobiliary malignancies, particularly gallbladder cancer. His landmark 2022 study, which compared robotic versus open extended cholecystectomy for T1a–T3 gallbladder cancer, represents a critical contribution to the field. By systematically evaluating short- and long-term outcomes across a seven-year cohort, Wu demonstrated that robotic extended cholecystectomy (REC) is both feasible and safe, challenging the traditional reliance on open surgery. This work, cited 9 times, provides the first matched comparison of these approaches, offering compelling evidence that robotic techniques can achieve comparable oncologic results while potentially reducing recovery times and complications. Wu’s research directly addresses a longstanding uncertainty in surgical oncology, bridging the gap between technological innovation and clinical practice. His findings have immediate implications for treatment protocols, empowering surgeons to adopt robotic methods with greater confidence. Beyond this study, Wu’s broader portfolio continues to explore the intersection of surgical robotics and cancer outcomes, positioning him as a key voice in the evolution of hepatobiliary surgery. For students and researchers, his work exemplifies how rigorous comparative studies can transform surgical standards and improve patient care.